RT Journal Article
SR Electronic
T1 A Biomarker-Centric Framework for the Prediction of Future Chronic Pain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.19.24306101
DO 10.1101/2024.04.19.24306101
A1 Fillingim, Matt
A1 Tanguay-Sabourin, Christophe
A1 Parisien, Marc
A1 Zare, Azin
A1 Guglietti, Gianluca V.
A1 Norman, Jax
A1 Petre, Bogdan
A1 Bortsov, Andrey
A1 Ware, Mark
A1 Perez, Jordi
A1 Roy, Mathieu
A1 Diatchenko, Luda
A1 Vachon-Presseau, Etienne
YR 2024
UL http://medrxiv.org/content/early/2024/04/20/2024.04.19.24306101.abstract
AB Chronic pain is a multifactorial condition presenting significant diagnostic and prognostic challenges. Biomarkers for the classification and the prediction of chronic pain are therefore critically needed. In this multi-dataset study of over 523,000 participants, we applied machine learning to multi-dimensional biological data from the UK Biobank to identify biomarkers for 35 medical conditions associated with pain (e.g., clinical diagnosis of rheumatoid arthritis, fibromyalgia, stroke, gout, etc.) or self-reported chronic pain (e.g., back pain, knee pain, etc). Biomarkers derived from blood immunoassays, brain and bone imaging, and genetics were effective in predicting medical conditions associated with chronic pain (area under the curve (AUC) 0.62-0.87) but not self-reported pain (AUC 0.50-0.62). Among the biomarkers identified was a composite blood-based signature that predicted the onset of various medical conditions approximately nine years in advance (AUC 0.59-0.72). Notably, all biomarkers worked in synergy with psychosocial factors, accurately predicting both medical conditions (AUC 0.69– 0.91) and self-report pain (AUC 0.71–0.92). Over a period of 15 years, individuals scoring high on both biomarkers and psychosocial risk factors had twice the cumulative incidence of diagnoses for pain-associated medical conditions (Hazard Ratio (HR): 2.26) compared to individuals scoring high on biomarkers but low on psychosocial risk factors (HR: 1.06). In summary, we identified various biomarkers for chronic pain conditions and showed that their predictive efficacy heavily depended on psychological and social influences. These findings underscore the necessity of adopting a holistic approach in the development of biomarkers to enhance their clinical utility.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Canadian Institutes of Health Research (CIHR 453096) and the Louise and Alan Edwards Grants in Pain Research. This study makes use of data from the UK Biobank (Project ID: 20802) and All of Us Research Program and we thank the UK Biobank and All of Us Research Program participants and teams for generating important research resources. Canadian Institutes of Health Research (CIHR), #RN441786 - 453096Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received ethics approval under IRB application number: A03-M20-21B (21-03-079).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data provided from the UKB are available to other investigators online upon permission granted by www.ukbiobank.ac.uk. Restrictions apply to the availability of these data, which were used under license for the current study (project ID 20802). The All of Us Research Program data is accessible for individuals at approved institutions. Details can be found at https://www.researchallofus.org/register/. OpenPain data can be accessed openly at https://www.openpain.org/.